David Luke Fischer, M.D., Ph.D. - Publications

Affiliations: 
2006-2010 Radiology, Neurology Michigan State University, East Lansing, MI 
 2010-2018 Translational Science and Molecular Medicine Michigan State University, East Lansing, MI 
 2018-2022 Neurology University of Alabama, Birmingham, Birmingham, AL, United States 
 2022- Neurology University of California, San Francisco, San Francisco, CA 
Area:
Alpha-Synuclein, Parkinson's disease, deep brain stimulation, brain-derived neurotrophic factor

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Ellens NR, Fischer DL, Meldau JE, Schroeder BA, Patra SE. External Ventricular Drain Placement Accuracy and Safety When Done by Midlevel Practitioners. Neurosurgery. 84: 235-241. PMID 29618119 DOI: 10.1093/neuros/nyy090  0.198
2018 Fischer DL, Sortwell CE. BDNF provides many routes toward STN DBS-mediated disease modification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30440081 DOI: 10.1002/Mds.27535  0.766
2018 Duffy MF, Collier TJ, Patterson JR, Kemp CJ, Luk KC, Tansey MG, Paumier KL, Kanaan NM, Fischer DL, Polinski NK, Barth OL, Howe JW, Vaikath NN, Majbour NK, El-Agnaf OMA, et al. Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration. Journal of Neuroinflammation. 15: 169. PMID 29843738 DOI: 10.1186/S12974-018-1202-9  0.7
2018 Fischer DL, Auinger P, Goudreau JL, Paumier KL, Cole-Strauss A, Kemp CJ, Lipton JW, Sortwell CE. Bdnf variant is associated with milder motor symptom severity in early-stage Parkinson's disease. Parkinsonism & Related Disorders. PMID 29759928 DOI: 10.1016/J.Parkreldis.2018.05.003  0.772
2017 Fischer DL, Manfredsson FP, Kemp CJ, Cole-Strauss A, Lipton JW, Duffy MF, Polinski NK, Steece-Collier K, Collier TJ, Gombash SE, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Does Not Modify the Functional Deficits or Axonopathy Induced by Nigrostriatal α-Synuclein Overexpression. Scientific Reports. 7: 16356. PMID 29180681 DOI: 10.1038/S41598-017-16690-X  0.687
2017 Fischer DL, Manfredsson FP, Sortwell CE. Can STN DBS protect both nigral somata and innervation of the striatum? Annals of Neurology. PMID 28985650 DOI: 10.1002/Ana.25064  0.77
2017 Fischer DL, Kemp CJ, Cole-Strauss A, Polinski NK, Paumier KL, Lipton JW, Steece-Collier K, Collier TJ, Buhlinger DJ, Sortwell CE. Subthalamic Nucleus Deep Brain Stimulation Employs TrkB Signaling for Neuroprotection and Functional Restoration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28607168 DOI: 10.1523/Jneurosci.2060-16.2017  0.776
2017 Su X, Fischer DL, Li X, Bankiewicz K, Sortwell CE, Federoff HJ. Alpha-Synuclein mRNA Is Not Increased. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28522034 DOI: 10.1016/J.Ymthe.2017.04.018  0.675
2016 Polinski NK, Manfredsson FP, Benskey MJ, Fischer DL, Kemp CJ, Steece-Collier K, Sandoval IM, Paumier KL, Sortwell CE. Impact of age and vector construct on striatal and nigral transgene expression. Molecular Therapy. Methods & Clinical Development. 3: 16082. PMID 27933309 DOI: 10.1038/Mtm.2016.82  0.769
2016 Fischer DL, Gombash SE, Kemp CJ, Manfredsson FP, Polinski NK, Duffy MF, Sortwell CE. Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson's Disease. Methods in Molecular Biology (Clifton, N.J.). 1382: 367-82. PMID 26611600 DOI: 10.1007/978-1-4939-3271-9_26  0.715
2015 Fischer DL, Collier TJ, Cole-Strauss A, Wohlgenant SL, Lipton JW, Steece-Collier K, Manfredsson FP, Kemp CJ, Sortwell CE. High-Frequency Stimulation of the Rat Entopeduncular Nucleus Does Not Provide Functional or Morphological Neuroprotection from 6-Hydroxydopamine. Plos One. 10: e0133957. PMID 26222442 DOI: 10.1371/Journal.Pone.0133957  0.765
2014 Gombash SE, Manfredsson FP, Mandel RJ, Collier TJ, Fischer DL, Kemp CJ, Kuhn NM, Wohlgenant SL, Fleming SM, Sortwell CE. Neuroprotective potential of pleiotrophin overexpression in the striatonigral pathway compared with overexpression in both the striatonigral and nigrostriatal pathways. Gene Therapy. 21: 682-93. PMID 24807806 DOI: 10.1038/Gt.2014.42  0.712
Show low-probability matches.